Morgan Stanley’s IDEX Biometrics ASA American Depositary Shares IDBA Stock Holding History

Morgan Stanley’s Portfolio IDBA Stock Details IDBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,389	Closed	-$11.8K	–	7798
2023 Q2	$11.8K	Hold	2,389	–	–	﹤0.01%	6758
2023 Q1	$15.9K	Hold	2,389	–	–	﹤0.01%	6711
2022 Q4	$19.3K	Hold	2,389	–	–	﹤0.01%	6707
2022 Q3	$12K	Hold	2,389	–	–	﹤0.01%	7023
2022 Q2	$21K	Hold	2,389	–	–	﹤0.01%	6973
2022 Q1	$37K	Buy	2,389 +750	+46%	+$14K	﹤0.01%	6851
2021 Q4	$44K	Hold	1,639	–	–	﹤0.01%	6876
2021 Q3	$34K	Hold	1,639	–	–	﹤0.01%	6893
2021 Q2	$31K	Buy	1,639 +1,539	+1,539%	+$33.2K	﹤0.01%	6846
2021 Q1	$2K	Buy	+100	New	+$2.47K	﹤0.01%	7298

Morgan Stanley's IDBA Position: Q3 2023 in Review

Morgan Stanley sold out of IDEX Biometrics ASA American Depositary Shares (IDBA) in Q3 2023, closing a stake of 2,389 shares — an estimated $11.8K sold.

Morgan Stanley first reported a position in IDBA in Q1 2021 and held it in 10 quarters. The position peaked at $44K in Q4 2021. 0 funds tracked by Wall St. Rank hold IDBA as of Q3 2023.

Morgan Stanley reported no remaining IDEX Biometrics ASA American Depositary Shares position as of Q3 2023 after selling out during the quarter.
Morgan Stanley sold 2,389 IDEX Biometrics ASA American Depositary Shares shares in Q3 2023, an estimated $11.8K.
Morgan Stanley first reported a position in IDEX Biometrics ASA American Depositary Shares in Q1 2021 and held it in 10 quarters.
Morgan Stanley's IDEX Biometrics ASA American Depositary Shares position peaked at $44K in Q4 2021.
0 funds tracked by Wall St. Rank held IDEX Biometrics ASA American Depositary Shares as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.